Ladenburg Thalmann Financial Services’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$11K	Buy	233 +60	+35%	+$2.65K	﹤0.01%	4468
2019 Q3	$5K	Buy	173 +24	+16%	+$711	﹤0.01%	4733
2019 Q2	$4K	Hold	149	–	–	﹤0.01%	4829
2019 Q1	$3K	Buy	149 +100	+204%	+$2.15K	﹤0.01%	4883
2018 Q4	$1K	Buy	+49	New	+$769	﹤0.01%	5158

Other funds holding RARX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ladenburg Thalmann Financial Services's RARX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Ra Pharmaceuticals, Inc. Common Stock (RARX) stake by 35% in Q4 2019, buying an estimated $2.65K and bringing the position to 233 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #4468.

Ladenburg Thalmann Financial Services first reported a position in RARX in Q4 2018 and has held it in 5 quarters since. 146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.

Ladenburg Thalmann Financial Services held 233 shares of Ra Pharmaceuticals, Inc. Common Stock worth $11K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 60 Ra Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $2.65K.
Ra Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4468 holding.
Ladenburg Thalmann Financial Services first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2018 and has held it in 5 quarters since.
146 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.